Pankaj Kumar Singh Selected Research

Tuberculosis (Tuberculoses)

1/2019	Pharmacophore modeling and molecular dynamics approach to identify putative DNA Gyrase B inhibitors for resistant tuberculosis.
12/2018	Chemical classes targeting energy supplying GyrB domain of Mycobacterium tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pankaj Kumar Singh Research Topics

Disease

30	Neoplasms (Cancer) 04/2024 - 05/2009
7	Lafora Disease 09/2018 - 02/2009
6	Lung Neoplasms (Lung Cancer) 06/2023 - 01/2016
5	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2015 - 02/2009
4	Breast Neoplasms (Breast Cancer) 04/2023 - 01/2018
4	COVID-19 09/2022 - 01/2020
3	Body Weight (Weight, Body) 11/2022 - 08/2005
3	Wounds and Injuries (Trauma) 01/2022 - 11/2014
3	Urinary Bladder Neoplasms (Bladder Cancer) 09/2021 - 01/2013
3	Spinal Fractures 01/2021 - 08/2014
3	Diabetes Complications 01/2020 - 12/2018
2	Residual Neoplasm 12/2023 - 05/2015
2	Kyphosis 07/2023 - 01/2021
2	Congenital Abnormalities (Deformity) 07/2023 - 06/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2023 - 05/2021
2	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2022 - 02/2021
2	Infections 11/2022 - 02/2022
2	Inflammation (Inflammations) 11/2022 - 10/2021
2	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 10/2015
2	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2022 - 01/2020
2	Insulin Resistance 06/2022 - 09/2021
2	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2022
2	Arthritis (Polyarthritis) 03/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 02/2022 - 08/2016
2	Hemangioma (Angioma) 11/2021 - 02/2016
2	Spinal Cord Diseases 11/2021 - 02/2016
2	Non-Muscle Invasive Bladder Neoplasms 09/2021 - 01/2015
2	Transitional Cell Carcinoma 09/2021 - 01/2015
2	Testicular Neoplasms (Testicular Cancer) 09/2021 - 01/2021
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 01/2015
2	Cardiotoxicity 06/2020 - 01/2018
2	Tuberculosis (Tuberculoses) 01/2019 - 12/2018
2	Carcinoma (Carcinomatosis) 06/2016 - 01/2013
2	Epilepsy (Aura) 01/2015 - 02/2009
2	Hepatocellular Carcinoma (Hepatoma) 01/2011 - 09/2009
1	Atopic Dermatitis (Atopic Eczema) 03/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 06/2023
1	Cutaneous Candidiasis 05/2023
1	Dermatitis 04/2023
1	Cutaneous Leishmaniasis 01/2023
1	Visceral Leishmaniasis (Kala Azar) 01/2023
1	monomelic Amyotrophy 01/2023
1	Dysbiosis 01/2023

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 06/2023 - 08/2005
6	Phosphotransferases (Kinase)IBA 11/2022 - 12/2013
4	ChitosanIBA 02/2024 - 05/2021
4	Messenger RNA (mRNA)IBA 09/2021 - 12/2012
4	GlycogenIBA 01/2018 - 02/2012
3	Tyrosine Kinase InhibitorsIBA 01/2024 - 10/2017
3	MicroRNAs (MicroRNA)IBA 11/2022 - 12/2012
3	EnzymesIBA 11/2022 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2015
3	Aldehyde Reductase (Aldose Reductase)IBA 01/2020 - 12/2018
2	ResveratrolIBA 03/2024 - 10/2021
2	LigandsIBA 07/2023 - 10/2018
2	Estrogen ReceptorsIBA 06/2023 - 01/2023
2	andrographolideIBA 01/2023 - 01/2023
2	Liposomes (Liposome)IBA 11/2022 - 01/2018
2	Insulin (Novolin)FDA Link 06/2022 - 09/2021
2	CholesterolIBA 06/2022 - 09/2021
2	Ethanol (Ethyl Alcohol)IBA 11/2021 - 02/2016
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 05/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 12/2018
2	polyolIBA 01/2020 - 12/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 11/2019
2	VaccinesIBA 01/2020 - 01/2015
2	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 01/2018
2	Drug CombinationsIBA 12/2018 - 01/2017
2	polyglucosanIBA 12/2015 - 02/2009
1	CytokinesIBA 03/2024
1	fucoidanIBA 01/2024
1	Dasatinib (BMS 354825)FDA Link 01/2024
1	Hyaluronic Acid (Hyaluronan)IBA 07/2023
1	pullulanIBA 07/2023
1	bazedoxifeneIBA 07/2023
1	Raloxifene Hydrochloride (Evista)FDA Link 07/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023
1	acalabrutinibIBA 06/2023
1	osimertinibIBA 06/2023
1	SilverIBA 05/2023
1	naringeninIBA 05/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2023
1	Histones (Histone)IBA 01/2023
1	Untranslated RNA (Noncoding RNA)IBA 01/2023

Therapy/Procedure

18	Therapeutics 04/2024 - 08/2013
6	Radiotherapy 04/2023 - 08/2013
4	Pedicle Screws 01/2022 - 08/2014
3	Decompression 12/2023 - 07/2015
3	Laminectomy 01/2023 - 02/2016
3	Craniotomy 11/2021 - 05/2013
2	Length of Stay 07/2023 - 01/2021
2	Precision Medicine 11/2022 - 01/2022
2	Sutures (Suture) 01/2022 - 11/2014
2	Immunotherapy 04/2021 - 01/2015
2	Drug Therapy (Chemotherapy) 05/2018 - 10/2015
1	Conservative Treatment 07/2023
1	Mechanical Ventilators (Ventilator) 07/2023